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Abstract: The ability of lentiviruses to continually evolve and escape immune control is 
the central impediment in developing an effective vaccine for HIV-1 and other lentiviruses. 
Equine infectious anemia virus (EIAV) is considered a useful model for immune control of 
lentivirus infection. Virus-specific cytotoxic T lymphocytes (CTL) and broadly neutralizing 
antibody effectively control EIAV replication during inapparent stages of disease, but after 
years of low-level replication, the virus is still able to produce evasion genotypes that lead 
to late re-emergence of disease. There is a high rate of genetic variation in the EIAV 
surface envelope glycoprotein (SU) and in the region of the transmembrane protein (TM) 
overlapped  by  the  major  exon  of  Rev.  This  review  examines  genetic  and  phenotypic 
variation in Rev during EIAV disease and a possible role for Rev in immune evasion and 
virus persistence. 
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1. Introduction 
Lentiviruses are characterized by high rates of mutation, recombination, and replication, resulting in 
multiple, diverse populations of viral variants that rapidly adapt to changes in the host environment. 
Understanding virus and host factors that shape the evolution and selection of virus variants in vivo is 
an  essential  component  of  preventive  and  therapeutic  strategies  to  control  lentivirus  infections  in 
humans  and  animals.  Equine  infectious  anemia  virus  (EIAV)  possesses  common  features  of  the 
Lentiviridae subfamily of retroviruses, including a complex genome organization, tropism for cells of 
the  monocyte/macrophage  lineage,  and  establishment  of  a  persistent,  life-long  infection.  Many 
lentivirus infections are characterized by a slow, chronic disease course, but infection of horses with 
EIAV can result in an acute, dynamic disease characterized by recurring cycles of viremia, fever, and 
thrombocytopenia. Most animals eventually gain control of viral replication, progressing to a clinically 
inapparent stage of disease, yet remain carriers of the virus for life. The dynamics of clinical disease 
and immune control make EIAV a good model to study the role of both host and viral mechanisms 
contributing to lentiviral persistence and pathogenesis. 
Genetic variation has been observed in the EIAV rev/tm overlapping reading frames, which encode 
the regulatory protein Rev and the cytoplasmic tail of the transmembrane (TM) protein [1–3]. Rev is 
an essential regulatory protein required for nucleocytoplasmic transport of incompletely spliced viral 
mRNAs encoding structural proteins. Variation in HIV-1 Rev has been shown to down-regulate the 
expression of viral late genes and alter sensitivity to Gag-specific cytotoxic T lymphocytes (CTL) [4]. 
In addition, CTL epitopes have been identified within HIV-1 Rev [5], as well as within EIAV Rev [6]. 
Genetic changes within rev may facilitate immune evasion directly by altering CTL epitopes in Rev, 
and/or indirectly through altering Rev nuclear export activity and expression of structural proteins. In 
this review, we focus on the variation and evolution of the rev gene over the course of EIAV infection 
in vivo. Our overriding hypothesis is that Rev variation contributes to viral persistence and survival in 
the host, so that understanding how and why rev varies may be key to effective antilentiviral strategies. 
2. Genetic Variation Alters Rev Activity 
Overlapping reading frames are expected to be more conserved than single reading frames as each 
mutation has an increased risk of causing a deleterious mutation and very few mutations are truly 
synonymous [7]. When one of the reading frames encodes a protein essential for virus replication, such 
as Rev, additional stabilizing selection could further reduce variation. Thus, it was surprising to find 
the second exon of rev exhibited high diversity, sometimes comparable to the highly variable surface 
protein [1,2]. Most of the genetic variation in the rev/tm overlapping reading frames occurred outside 
known functional domains of Rev, and was thought to be of minimal consequence for Rev activity. 
However, Belshan et al. [3] found that polymorphisms in rev/tm resulted in significant increases or 
decreases in Rev activity. This supported the hypothesis that variation in Rev may be an important 
mechanism for regulation of virus replication in vivo and provided a basis for more extensive analyses 
of Rev variation in experimentally infected horses [8–10].  Viruses 2011, 3                         
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3. Longitudinal Studies of Rev Variation in Vivo 
3.1. Rev Subpopulations Evolve During Disease Progression, Sometimes Coexisting or Recurring 
Longitudinal analysis of Rev variation in vivo revealed that novel rev/tm variants arose throughout 
infection [8,9]. Overall, genetic variation in Rev was characterized by a low level of synonymous 
changes in the majority of Rev codons, punctuated by a high rate of non-synonymous changes at a 
limited number of codons [10]. The marked variation in Rev was not accompanied by co-variation in 
the  Rev-Responsive  Element  (RRE)  [9,11].  Detailed  longitudinal  analysis  in  two  experimentally 
infected horses suggested that the rev/tm population was comprised of two distinct sub-populations 
that co-existed during infection [9]. One sub-population, Group A, appeared to accumulate changes in 
a linear, time-dependent manner, while the other sub-population, Group B, evolved radially from a 
common variant. Over time, the two sub-populations cycled in predominance coincident with changes 
in the disease state (Figure 1), suggesting that the two groups differed in selective advantage. When 
serum from the first pony (pony 524) was used to infect a second (pony 625), the populations were 
seen to persist through transmission events. 
Figure 1. Partition analysis identifies two co-existing sub-populations of rev variants [9]. 
The groups present at each time point were found using the program PAQ [9,12]. The 
relative size of each group represents the proportion of the population contained within the 
group at that time point. The central Rev variant for each group is shown, and the arrows 
show from which group the central variant likely evolved. Groups that overlap indicate that 
both groups share at least one variant. The different groups are designated Group 1 (red), 
Group 2 (blue), and Group 3 (green). The day post-infection and clinical stages of infection 
are indicated. (A) Partition analysis of pony 524 rev nucleotide variants at sequential times 
following infection. (B) Partition analysis of pony 625 rev nucleotide variants at sequential 
times following infection. 
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3.2. Sub-population Rev Variants Differ in Nuclear Export Activity and Replication Phenotype 
Biological  characterization  of  Rev  variants  representative  of  Group  A  and  Group  B  were 
undertaken to determine if the sub-populations differed in Rev phenotype. Seventeen variants from the 
two ponies, representing 54–67% of the sampled in vivo population, were tested for Rev activity in 
transient expression assays. For 16 of the 17 variants tested, Rev activity segregated according to the 
genetic groups identified by phylogenetic and partition analyses. Further, Rev activity of all variants 
from Group A was significantly higher than the activity of all variants from Group B (p < 0.0001). To 
examine possible changes in Rev activity during disease progression, the activity of each tested variant 
and  its  frequency  in  the population was used  to  calculate  an  average  Rev activity  at each of the 
sampled time points [8]. Comparison of the average Rev activity with clinical parameters of disease 
progression indicated that Rev activity was highest during the recurrent febrile and late febrile stages 
of EIA (Figure 2). Rev activity was correlated with temperature (p = 0.007), and Rev activity in the 
recurrent febrile stage was significantly higher than Rev activity in the inapparent stage of infection  
(p  =  0.010).  Additionally,  replication  competent  chimeric  viruses  containing  rev/tm  variants 
representative of Group A replicated faster, and to higher levels, than Group B viruses in vitro. The  
co-existence  of  genetically  distinct  viral  sub-populations  that  differ  in  phenotype  provides  great 
adaptability to environmental changes within the infected host.  
Figure  2.  Changes  in  Rev  activity  during  progression  of  clinical  disease  [8].  In  vitro 
biological activity of Rev variants from pony 524 was quantified in transient transfection 
assays using 293T cells as previously described [3]. Briefly, Rev variant cDNAs were  
co-transfected with a chloramphenicol acetyltransferase (CAT) reporter plasmid (pERRE-
All) in HEK293T cells and CAT activity was quantified as percent acetylation. The results 
are  presented  as  a  percentage  of  activity  compared  to  R1,  the  founder  variant  in  the 
inoculum. The overall Rev activity for each time point was calculated as the average Rev 
activity of tested variants, weighted by the frequency of the tested variant in the sampled 
population. Solid bars indicate the rectal temperature of pony 524. The clinical stages of 
disease are indicated as: Acute, Chronic, Inapparent, and Rec (recrudescent). 
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4. Selection in an Overlapping Reading Frame 
Given the high diversity in the second rev exon and the strong association between Rev phenotype 
and clinical disease, we wanted to determine whether the diversity was caused by selection for change 
in  rev,  tm,  or  both.  Standard  methods  for  detecting  selection  that  test  for  an  elevated  rate  of 
nonsynonymous relative to synonymous mutations—the so-called dN/dS ratio [13]—cannot work in 
overlapping reading frames where most synonymous mutations in one frame are nonsynonymous in 
the other. Failure to account for cryptic selection on synonymous mutations can lead to false evidence 
for  selection  at  the  protein  level  [14–16].  Indeed,  purifying  selection  on  HIV-1  RNA  functional 
elements contained within genes are correlated with unusually large dN/dS ratios [17]. 
4.1. Model for Estimating Selection in Overlapping Reading Frames 
Hein [7] extended the Li counting method [18] and Pedersen [19] extended the likelihood-based 
methods [20,21] for estimating selection in open reading frames to handle overlapping frames. Both 
models classify mutations into four categories: SS mutations are synonymous in both reading frames, 
SN are synonymous in the first reading frame, nonsynonymous in the second, NS the opposite, and 
NN are nonsynonymous in both. Since the Pedersen model [19] only works on pairs of sequences, 
Sabath [22] approximated the Peterson model in order to analyze more data at the cost of assuming 
independent evolution in each overlapping reading frame. We have recently proposed an alternative 
approximation  to  the  Pedersen  model  that  assumes  some  sites  are  invariant  (cannot  mutate)  and  
all mutations are observed (a form of parsimony) [23]. While these approximations are not reasonable 
for  highly  variable  genes,  they  represent  a  reasonable  compromise  in  relatively  conserved  
overlapping regions. 
Briefly,  the  model  takes  an  alignment  of  wholly  overlapped  reading  frames.  One  sequence  is 
identified as the ancestral sequence; the consensus sequence will often suffice if none is known. The 
alignment  is  then  partitioned  at  non-segregating  sites  into  a  collection  of  independently  evolving 
variable-length fragments. The non-segregating sites used to fragment the alignment are treated as 
invariant sites that can never mutate. There are multiple choices of invariant sites, but the results are 
minimally affected by the choice (data not shown). Under the parsimony assumption, we have derived 
the probability of transitioning between any pair of fragments for a model that has specific rates for 
transversions relative to transitions and NS, SN, and NN relative to SS mutations. For example, one 
may interpret the relative rate of NS to SS mutations as a dNS/dSS ratio. All sequences are assumed to 
evolve  independently  from  the  ancestral  sequence.  This  approximation  avoids  the  need  to  infer  a 
complex phylogenetic tree or network, but may tend to overweight ancient relative to recent mutations. 
4.2. Evidence for Selection in Both Rev and TM 
Analyses of all 146 rev/tm sequences obtained during EIAV infection of pony 524 support the full 
model with one transversion/transition bias and three distinct selection ratios: dNS/dSS, dSN/dSS, and 
dNN/dSS, where the first letter denotes changes in rev, and the second letter denotes changes in tm 
(Figure 3). In particular, the hypothesis of independent selection in the two reading frames is rejected. 
Interestingly, there appears to be greater diversifying selection on the second frame encoding tm, since Viruses 2011, 3                         
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the  relative  rate  of  SN  (0.26)  mutations  is  higher  than  NS  mutations  (0.13),  however  there  is  a 
surprisingly high selection or tolerance for doubly nonsynonymous NN mutations (0.47). Indeed, the 
propensity to NN mutations is the reason for rejecting the hypothesis of independent selection and 
suggests the virus may have adopted sites that can change both proteins in order to allow evolution in 
these genes. It is remains unclear which of the two protein products is the selective target of these 
NN changes.  
Figure 3. Analysis of mutations in rev/tm overlapping reading frames. (A) Categories of 
mutations in overlapping reading frames indicating the type of mutation in Rev and TM.  
(B)  The  difference  between  the  observed  and  expected  number  of  each  mutation  type  
(SS, NS, SN, and NN) is plotted for each of the fragments along the Rev open reading 
frame. Expected numbers were computed as the mean of 160 simulations of the model 
using  the  maximum  likelihood  estimated  parameters.  Observed  numbers  were  counted 
directly from the Pony 524 rev/tm alignment. The blue bars above the line indicate more 
mutations of the designated type were observed than expected in that fragment whereas red 
bars below indicate fewer mutations were observed than expected. Width of the block 
indicates the length of the fragment. All differences were ranked from smallest to largest. 
Dark blue indicates the top 5% of differences; dark red indicates bottom 5% of differences. 
Functional domains important for Rev activity are depicted in red and the non-essential 
region is blue. Asterisks indicate fragments containing amino acids shown to be essential 
for Rev activity, while delta symbols indicate amino acids shown to modulate Rev activity.  
 Viruses 2011, 3                         
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By comparing the observed number of each mutation to the expected under the full, fitted model, it 
is  possible  to  identify  fragments  with  unusually  low  or  high  numbers  of  each  type  of  mutation  
(Figure 3). One fragment near the end of the overlap with more SN mutations than expected could 
indicate selection for change at this site in TM. Another fragment just downstream of the Rev nuclear 
export signal (NES) has elevated NS mutations, indicative of possible selection in Rev. Four fragments 
(marked with Δ in Figure 3) with more NN mutations than expected, including two fragments in the 
nonessential  region  of  Rev  [24],  were  found  to  significantly  change  Rev  activity  in  transient 
expression assays [10]. Several fragments have fewer mutations than expected, possibly indicating 
essential regions. Four fragments (marked with asterisks in Figure 3) deficient in NN mutations align 
with known lethal mutations in the NES and RNA binding domains (RBD) of Rev. 
5. Genetic Determinants of Rev Phenotype 
The results of the selection analyses suggested fragments that may be under selection in the Rev 
protein. Genetic variation was observed in 121 of 135 Rev codons; however, the mutations at these 
positions occurred at a low frequency (less than 2%), and many of these were synonymous changes; 70 
amino acid positions were 100% conserved. However, there were nine highly variable amino acid 
positions  in  Rev  sequences  extracted  from  pony  524,  which  (together)  experienced  a  total  of  ten 
distinct high frequency amino acid mutations from the inoculum consensus [10]. All but one of the 
highly  variable  amino  acid  positions  observed  in  vivo  were  found  outside  the  known  functional 
domains of EIAV Rev, and four of the highly variable positions occurred within a non-essential region 
of Rev [24–27]. Nonetheless, nine of the ten naturally occurring amino acid substitutions were found 
to significantly alter Rev activity, either as single mutations or in the context of cumulatively fixed 
mutations [10]. 
The effect of variation at each of the highly variable positions was assessed in transient expression 
assays [10]. Seven of the ten amino acid mutations significantly altered Rev phenotype; six increased 
Rev activity and one decreased Rev activity. All of these changes occurred in fragments found to have 
somewhat more NN mutations than expected (Figure 3), consistent with selection for effects on Rev 
activity. The phenotype analyses demonstrated that the majority of Rev mutations observed at a high 
frequency  in  vivo  were  alone  sufficient  to  cause  significant  changes  in  nuclear  export  activity. 
Moreover, EIAV Rev nuclear export activity was found to be highly sensitive to point mutations 
outside  essential  functional  domains.  The  presence  of  multiple  mutational  pathways  to  high  Rev 
activity could confer flexibility on a protein whose evolution is constrained by an overlapping reading 
frame and/or immune epitopes. Further, the complexity of these pathways suggests it will be difficult 
to predict Rev phenotype based on sequence alone; consequently, the biological significance of Rev 
variation may be underestimated. 
6. Rev Variation and Immune Evasion 
Although longitudinal studies in a limited number of horses suggest that Rev phenotype contributes 
to variant selection in vivo, the specific selective pressures on Rev are unknown. Genetic changes 
within rev/tm may facilitate immune evasion by directly altering CTL epitopes, and it is likely that 
some of the observed variation in Rev is due to antigenic escape from Rev-specific CTL. CTL epitopes Viruses 2011, 3                         
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have been identified within EIAV Rev [6], and a high-avidity CTL response to epitopes within Rev 
has been associated with low viral loads and mild clinical disease [6]. In one horse, two CTL epitopes 
were  identified  and  mapped  to  conserved  regions  important  for  Rev  activity,  and  there  was  little 
variation observed within the CTL epitopes. The presence of high-avidity CTLs to conserved epitopes 
may  constrain  virus  options  for  escape,  leading  to  effective  immune  control  and  lack  of  disease 
progression. It is important to note that Mealey [6] also observed some variation at epitopes outside 
known functional domains, including the variable, non-essential region; however, it is not known if 
these changes alter Rev activity.  
A  second  mechanism  by  which  Rev  can  contribute  to  immune  evasion  is  down  regulation  of 
structural gene expression. Bobbitt et al. [4] demonstrated that variation in HIV-1 Rev activity could 
alter sensitivity to CTL killing by down regulating viral late gene expression. A single amino acid 
substitution in HIV-1 Rev resulted in a 2–3 fold reduction in Gag expression and a significant decrease 
in CTL killing. Further, primary HIV-1 isolates from asymptomatic patients showed reduced Rev 
activity, reduced levels of Gag expression, and increased resistance to CTL killing. Rev-attenuated 
phenotypes  have  been  associated  with  nonprogressive  HIV-1  infection  [28–30],  suggesting  that 
variation  in  Rev  could  alter  virus  replication  levels  in  vivo  and  modify  the  clinical  outcome  of 
infection. The detailed analyses of Rev variation in EIAV infected horses provide basis for further 
evaluation of mechanisms by which Rev variation may alter levels of virus replication in vivo and may 
contribute to changes in clinical disease. Ongoing and additional studies in EIAV-infected horses will 
increase our understanding of the role of Rev variation in immune evasion and lentiviral persistence. 
7. Summary and Conclusions 
A number of early studies of EIAV variation in vivo [1,2] reported considerable genetic variation in 
Rev,  which  is  striking  considering  that  the  second  exon  of  Rev  overlaps  with  the  reading  frame 
encoding  the  envelope  transmembrane  protein.  Subsequent  studies  have  shown  that  the  genetic 
variation  leads  to  detectable  changes  in  Rev  activity  and  virus  replication.  A  novel  analysis  of 
selection on the overlapping reading frames has revealed a somewhat higher rate of nonsynonymous 
mutation in tm; however, most evolution is occurring through double nonsynonymous (NN) mutations. 
While the statistical analysis cannot reveal whether the NN mutations are tolerated or selected in one 
or the other, additional phenotypic analyses have shown the most common NN mutations alter Rev 
nuclear export activity. In addition, there are multiple configurations of the protein that result in the 
same Rev activity, which can allow the overlapping reading frames to accommodate other selection 
pressures,  for  example,  at  CTL  epitopes  or  in  TM.  The  detailed  analyses  of  Rev  variation  in  
EIAV-infected pony 524 has raised a number of intriguing hypotheses about EIAV evolution and 
adaption  during  disease  progression  in  a  horse  that  passed  through  clearly  demarcated  stages  of 
disease. Study of additional horses will be needed to confirm these hypotheses or further enrich our 
understanding of pathogen-host interactions in EIAV and other related lentivirus infections. Viruses 2011, 3                         
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